Aguiar LMV, Nobre HV, Macêdo DS,
Oliveira AA, Freitas RM, Vasconcelos
SM, Cunha GMA, Sousa FCF, Viana
GSB. 2006. Neuroprotective effects of
caffeine in the model of 6-
hydroxydopamine lesion in rats.
Pharmacol Biochem Behav, 84: 415-419.
Alizadeh Makvandi A, Khalili M, Roghani M,
Amiri Moghaddam S. 2021. Hesperetin
ameliorates electroconvulsive therapyinduced memory impairment through
regulation of hippocampal BDNF and
oxidative stress in a rat model of
depression. J Chem Neuroanat, 117:
102001.
Antunes MS, Goes ATR, Boeira SP, Prigol M,
Jesse CR. 2014. Protective effect of
hesperidin in a model of Parkinson's
disease induced by 6-hydroxydopamine in
aged mice. Nutr, 30: 1415-1422.
Antunes MS, Ladd FVL, Ladd AABL,
Moreira AL, Boeira SP, Cattelan Souza L.
2021. Hesperidin protects against
behavioral alterations and loss of
dopaminergic neurons in 6-OHDAlesioned mice: the role of mitochondrial
dysfunction and apoptosis. Metab Brain
Dis, 36: 153-167.
Baluchnejadmojarad T, Mansouri M, Ghalami
J, Mokhtari Z, Roghani M. 2017. Sesamin
imparts neuroprotection against
intrastriatal 6-hydroxydopamine toxicity
by inhibition of astroglial activation,
apoptosis, and oxidative stress. Biomed
Pharmacother, 88: 754-761.
Baluchnejadmojarad T, Rabiee N, Zabihnejad
S, Roghani M. 2017. Ellagic acid exerts
protective effect in intrastriatal 6-
hydroxydopamine rat model of
Parkinson’s disease: Possible involvement
of ERβ/Nrf2/HO-1 signaling. Brain Res,
1662: 23-30.
Bradford MM. 1976. A rapid and sensitive
method for the quantitation of microgram
quantities of protein utilizing the principle
of protein-dye binding. Anal Biochem,
72: 248-254.
Chandrasekhar Y, Phani Kumar G, Ramya E
M, Anilakumar KR. 2018. Gallic acid
protects 6-OHDA induced neurotoxicity
by attenuating oxidative stress in human
dopaminergic cell line. Neurochem Res,
43: 1150-1160.
Chen M-c, Ye Y-y, Ji G, Liu J-w. 2010.
Hesperidin upregulates heme oxygenase-1
to attenuate hydrogen peroxide-induced
cell damage in hepatic L02 cells. J Agric
Food Chem, 58: 3330-3335.
Chiaravalloti ND, Ibarretxe-Bilbao N, DeLuca
J, Rusu O, Pena J, García-Gorostiaga I,
Ojeda N. 2014. The source of the memory
impairment in Parkinson's disease:
Acquisition versus retrieval. Mov Disord,
29: 765-771.
Esterbauer H, Cheeseman KH. 1990.
Determination of aldehydic lipid
peroxidation products: malonaldehyde
Hajizadeh Moghaddam et al.
AJP, Vol. 13, No. 3, May-Jun 2023 300
and 4-hydroxynonenal. Methods
Enzymol, 186: 407-421.
Fathi M, Varshosaz J, Mohebbi M, Shahidi F.
2013. Hesperetin-loaded solid lipid
nanoparticles and nanostructure lipid
carriers for food fortification: preparation,
characterization, and modeling. Food
Bioprocess tech, 6: 1464-1475.
Fine JM, Stroebel BM, Faltesek KA, Terai K,
Haase L, Knutzen KE, Kosyakovsky J,
Bowe TJ, Fuller AK, Frey WH, Hanson
LR. 2020. Intranasal delivery of low-dose
insulin ameliorates motor dysfunction and
dopaminergic cell death in a 6-OHDA rat
model of Parkinson’s Disease. Neurosci
Lett, 714: 134567.
Fukuzawa K, Tokumurai A. 1976. Glutathione
peroxidase activity in tissues of vitamin
E-deficient mice. J Nutr Sci Vitaminol,
22: 405-407.
Gaba B, Khan T, Haider MF, Alam T, Baboota
S, Parvez S, Ali J. 2019. Vitamin E
loaded naringenin nanoemulsion via
intranasal delivery for the management of
oxidative stress in a 6-OHDA parkinson’s
disease model. Biomed Res Int, 2019:
2382563.
Genet S, Kale RK, Baquer NZ. 2002.
Alterations in antioxidant enzymes and
oxidative damage in experimental diabetic
rat tissues: effect of vanadate and
fenugreek (Trigonella foenum graecum).
Mol Cell Biochem, 236: 7-12.
Ghaffari F, Hajizadeh Moghaddam A, Zare M.
2018. Neuroprotective effect of quercetin
nanocrystal in a 6-hydroxydopamine
model of parkinson disease: biochemical
and behavioral evidence. Basic Clin
Neurosci, 9: 317-324.
Hajizadeh Moghaddam A, Ahmadnia H,
Jelodar SK, Ranjbar M. 2020. Hesperetin
nanoparticles attenuate anxiogenic-like
behavior and cerebral oxidative stress
through the upregulation of antioxidant
enzyme expression in experimental
dementia of Alzheimer’s type. Neurol
Res, 42: 477-486.
Hajizadeh Moghaddam A, Shirej Pour Y,
Mokhtari Sangdehi SR, Hasantabar V.
2021. Evaluation of hesperetin-loaded on
multiple wall carbon nanotubes on
cerebral ischemia/reperfusion injury in
rats. Biomed Pharmacother, 138: 111467.
Haleagrahara N, Siew CJ, Mitra NK, Kumari
M. 2011. Neuroprotective effect of
bioflavonoid quercetin in 6-
hydroxydopamine-induced oxidative
stress biomarkers in the rat striatum.
Neurosci Lett, 500: 139-143.
He R, Yan X, Guo J, Xu Q, Tang B, Sun Q.
2018. Recent Advances in Biomarkers for
Parkinson’s Disease. Front Aging
Neurosci, 10: 305.
Hernandez-Baltazar D, Zavala-Flores LM,
Villanueva-Olivo A. 2017. The 6-
hydroxydopamine model and
parkinsonian pathophysiology: Novel
findings in an older model. Neurología,
32: 533-539.
Hritcu L, Ciobica A, Artenie V. 2008. Effects
of right-unilateral 6-hydroxydopamine
infusion-induced memory impairment and
oxidative stress: relevance for Parkinson’s
disease. Open Life Sci, 3: 250-257.
Hritcu L, Foyet HS, Stefan M, Mihasan M,
Asongalem AE, Kamtchouing P. 2011.
Neuroprotective effect of the methanolic
extract of Hibiscus asper leaves in 6-
hydroxydopamine-lesioned rat model of
Parkinson's disease. J Ethnopharmacol,
137: 585-591.
Ishola IO, Jacinta AA, Adeyemi OO. 2019.
Cortico-hippocampal memory enhancing
activity of hesperetin on scopolamineinduced amnesia in mice: role of
antioxidant defense system, cholinergic
neurotransmission and expression of
BDNF. Metab Brain Dis, 34: 979-989.
Kakran M, Sahoo G, Li L. 2015. Fabrication
of nanoparticles of silymarin, hesperetin
and glibenclamide by evaporative
precipitation of nanosuspension for fast
dissolution. Pharm Anal Acta, 6:
1000326.
Kashiwagi A, Asahina T, Nishio Y, Ikebuchi
M, Tanaka Y, Kikkawa R, Shigeta Y.
1996. Glycation, oxidative stress, and
scavenger activity: glucose metabolism
and radical scavenger dysfunction in
endothelial cells. Diabetes, 45: S84-S86.
Kesmati M, Torabi M, Pourreza N,
Abdollahzadeh R, Rahiminezhadseta R,
Banitorof MB. 2020. Effects of
nanoparticle and conventional-size
suspensions of MgO and ZnO on
recognition memory in mice.
Neurophysiol, 52: 23-30.
Khalaj R, Hajizadeh Moghaddam A, Zare M.
2018. Hesperetin and it nanocrystals
ameliorate social behavior deficits and
Nano-hesperetin improves Parkinson’s disease
AJP, Vol. 13, No. 3, May-Jun 2023 301
oxido-inflammatory stress in rat model of
autism. Int J Dev Neurosci, 69: 80-87.
kheradmand E, Hajizadeh Moghaddam A,
Zare M. 2018. Neuroprotective effect of
hesperetin and nano-hesperetin on
recognition memory impairment and the
elevated oxygen stress in rat model of
Alzheimer’s disease. Biomed
Pharmacother, 97: 1096-1101.
Kiasalari Z, Khalili M, Baluchnejadmojarad T,
Roghani M. 2016. Protective effect of oral
hesperetin against unilateral striatal 6-
hydroxydopamine damage in the rat.
Neurochem Res, 41: 1065-1072.
Kuruvilla KP, Nandhu MS, Paul J, Paulose
CS. 2013. Oxidative stress mediated
neuronal damage in the corpus striatum of
6-hydroxydopamine lesioned Parkinson's
rats: Neuroprotection by serotonin,
GABA and bone marrow cells
supplementation. J Neurol Sci, 331: 31-
37.
Maitra U, Harding T, Liang Q, Ciesla L. 2021.
GardeninA confers neuroprotection
against environmental toxin in a
Drosophila model of Parkinson’s disease.
Commun Biol, 4: 162.
Martínez-Boo N. 2021. The role of dietary
habits in Parkinson's disease signs and
symptoms: A systematic review. Rev
Cient Soc Esp Enferm Neurol, 54: 30-37.
Mary Lazer L, Sadhasivam B, Palaniyandi K,
Muthuswamy T, Ramachandran I,
Balakrishnan A, Pathak S, Narayan S,
Ramalingam S. 2018. Chitosan-based
nano-formulation enhances the anticancer
efficacy of hesperetin. Int J Biol
Macromol, 107: 1988-1998.
Moghaddam AH, Mokhtari Sangdehi SR,
Ranjbar M, Hasantabar V. 2020.
Preventive effect of silymarin-loaded
chitosan nanoparticles against global
cerebral ischemia/reperfusion injury in
rats. Eur J Pharmacol, 877: 173066.
Mohanty C, Das M, Sahoo SK. 2012.
Emerging role of nanocarriers to increase
the solubility and bioavailability of
curcumin. Expert Opin drug del, 9: 1347-
1364.
Muhammad T, Ikram M, Ullah R, Rehman
SU, Kim MO. 2019. Hesperetin, a citrus
flavonoid, attenuates LPS-induced
neuroinflammation, apoptosis and
memory impairments by modulating
TLR4/NF-κB signaling. Nutrients, 11:
648.
Paxinos G, Watson C. 2006. The rat brain in
stereotaxic coordinates: hard cover
edition: Elsevier; 6th Edition.
Pinto R, Bartley W. 1969. The effect of age
and sex on glutathione reductase and
glutathione peroxidase activities and on
aerobic glutathione oxidation in rat liver
homogenates. Biochem J, 112: 109-115.
Roohbakhsh A, Parhiz H, Soltani F, Rezaee R,
Iranshahi M. 2014.
Neuropharmacological properties and
pharmacokinetics of the citrus flavonoids
hesperidin and hesperetin — A minireview. Life Sci, 113: 1-6.
Samie A, Sedaghat R, Baluchnejadmojarad T,
Roghani M. 2018. Hesperetin, a citrus
flavonoid, attenuates testicular damage in
diabetic rats via inhibition of oxidative
stress, inflammation, and apoptosis. Life
Sci, 210: 132-139.
Shete G, Pawar YB, Thanki K, Jain S, Bansal
AK. 2015. Oral bioavailability and
pharmacodynamic activity of hesperetin
nanocrystals generated using a novel
bottom-up technology. Mol Pharm, 12:
1158-1170.
Shrivastava P, Vaibhav K, Tabassum R, Khan
A, Ishrat T, Khan MM, Ahmad A, Islam
F, Safhi MM, Islam F. 2013. Antiapoptotic and Anti-inflammatory effect of
Piperine on 6-OHDA induced Parkinson's
Rat model. J Nutr Biochem, 24: 680-687.
Zeng F, Wang D, Tian Y, Wang M, Liu R, Xia
Z, Huang Y. 2021. Nanoemulsion for
improving the oral bioavailability of
hesperetin: formulation optimization and
absorption mechanism. J Pharm Sci, 110:
2555-2561.